Tessler H H, Farber M D
Department of Ophthalmology and Visual Sciences, UIC Eye Center, University of Illinois, Chicago College of Medicine 60612.
Ophthalmology. 1993 Aug;100(8):1206-9. doi: 10.1016/s0161-6420(93)31504-6.
The authors studied the safety of intraocular lens (IOL) implantation in patients with uveitis.
The authors prospectively randomized 26 patients with chronic iridocyclitis (22 patients) or pars planitis (4 patients) to undergo IOL implantation or no IOL implantation at the time of cataract surgery.
There was no statistical difference in visual acuity results at 1 year between the two groups. There was a trend toward better visual acuity in patients with chronic iridocyclitis without IOLs. Cocoon-like dense fibrous membranes enveloped the IOL in two patients.
The authors conclude that IOLs are relatively safe in patients with chronic iridocyclitis but that only a much larger study could determine if the trend toward better visual acuity without an IOL was real.
作者研究了葡萄膜炎患者人工晶状体（IOL）植入的安全性。
作者前瞻性地将26例慢性虹膜睫状体炎患者（22例）或周边葡萄膜炎患者（4例）随机分为两组，一组在白内障手术时植入IOL，另一组不植入IOL。
两组患者1年后的视力结果无统计学差异。未植入IOL的慢性虹膜睫状体炎患者的视力有改善趋势。两名患者的IOL被茧状致密纤维膜包裹。
作者得出结论，IOL在慢性虹膜睫状体炎患者中相对安全，但只有规模大得多的研究才能确定不植入IOL时视力改善的趋势是否真实。
